These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14587226)

  • 1. [The psychosocial approach to the planning and implementation of vaccine trials for HIV infection].
    Starace F; Embrione F; Fusco ML; Cafaro L
    Ann Ist Super Sanita; 2003; 39(2):259-66. PubMed ID: 14587226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community heroes or "high-risk" pariahs? Reasons for declining to enroll in an HIV vaccine trial.
    Newman PA; Daley A; Halpenny R; Loutfy M
    Vaccine; 2008 Feb; 26(8):1091-7. PubMed ID: 18237829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of relevant cultural considerations is essential for the success of a vaccine.
    Stanton BF
    J Health Popul Nutr; 2004 Sep; 22(3):286-92. PubMed ID: 15609781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials.
    MacQueen KM; Buchbinder SP; Douglas JM; Judson FN; McKirnan DJ; Bartholow BN
    AIDS Public Policy J; 1996; 11(2):104-12. PubMed ID: 10915243
    [No Abstract]   [Full Text] [Related]  

  • 6. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials.
    Swartz L; Kagee A; Kafaar Z; Smit J; Bhana A; Gray G; Lesch A; Lindegger G; Milford C; Richter L; Seedat S; Skhosana N; Stein DJ
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):89-92. PubMed ID: 16533797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection.
    MacQueen KM; Buchbinder S; Douglas JM; Judson FN; McKirnan DJ; Bartholow B
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S261-4. PubMed ID: 7865314
    [No Abstract]   [Full Text] [Related]  

  • 8. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
    Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
    Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attitudes toward and experiences with clinical research among current and potential research subjects].
    Madsen SM
    Ugeskr Laeger; 2004 Jun; 166(24):2343-4. PubMed ID: 15281573
    [No Abstract]   [Full Text] [Related]  

  • 10. [Motivation and barriers to participation in clinical trials].
    Gaul C; Schmidt T; Helm J; Hoyer H; Haerting J
    Med Klin (Munich); 2006 Nov; 101(11):873-9. PubMed ID: 17235473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of HIV vaccine trial participation: an Indian perspective.
    Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
    Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.
    Allen M; Lau CY
    Soc Sci Med; 2008 Feb; 66(4):945-51. PubMed ID: 18162272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What motivates minorities to participate in research?
    Khaliq W; Gross M; Thyagarajan B; Jones-Webb R
    Minn Med; 2003 Oct; 86(10):39-42. PubMed ID: 14621943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social and behavioral science in HIV vaccine trials: a gap assessment of the literature.
    Lau CY; Stansbury JP; Gust DA; Kafaar Z
    Expert Rev Vaccines; 2009 Feb; 8(2):179-90. PubMed ID: 19196198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research.
    Orentlicher D
    Hastings Cent Rep; 2005; 35(5):20-8. PubMed ID: 16295261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to participate in HIV vaccine research in a peri-urban South African community.
    Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
    Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake.
    Rudy ET; Newman PA; Duan N; Kelly EM; Roberts KJ; Seiden DS
    AIDS Educ Prev; 2005 Jun; 17(3):253-67. PubMed ID: 16006211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family patterns of decision-making in pediatric clinical trials.
    Snethen JA; Broome ME; Knafl K; Deatrick JA; Angst DB
    Res Nurs Health; 2006 Jun; 29(3):223-32. PubMed ID: 16676342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.